---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-016366"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2025-09-30T23:59:59+00:00"
generated_at: "2026-05-17T05:16:42.492566+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# bioAffinity closes $4.8M public offering; Nasdaq compliance extension received

## Summary
- Gross proceeds of $4.8M from sale of 1,921,761 shares/pre-funded warrants at $2.50/$2.493 per unit.
- After closing and warrant exercises, common shares outstanding total 3,100,402.
- 1-for-30 reverse stock split effective Sept 19; eliminated ~$4M in derivative liabilities.
- Company believes it regained compliance with Nasdaq minimum bid price and equity requirements; extension granted to Oct 2.
- Warrant amendments and exercises contributed ~$2.8M equity and ~$1.3M cash.

## SEC filing metadata
- accession: 0001493152-25-016366
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2025-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315225016366/0001493152-25-016366-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315225016366/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-016366
- JSON: https://secwatch.observer/filing/0001493152-25-016366.json
- Plain text: https://secwatch.observer/filing/0001493152-25-016366.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.